Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ADCT-602 |
Trade Name | |
Synonyms | Epratuzumab-cys-tesirine|hLL2-cys-PBD|ADCT602|hLL2-cys-SG3249 |
Drug Descriptions |
ADCT-602 (Epratuzumab-cys-tesirine) is an antibody-drug conjugate (ADC) comprising an antibody that targets CD22 (epratuzumab) linked to SG3249 (tesirine), which delivers the cytotoxic agent to CD22-expressing tumor cells, potentially resulting in decreased tumor growth (Blood 2016 128:4176). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C155794 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ADCT-602 | ADCT-602 | 0 | 1 |